Understanding the Progressive NGS-based RNA-sequencing Market Size, Share, and Key Players

NGS-based RNA-sequencing Market is valued at USD 1,080 million in 2022, and it is projected to reach USD 6,800 million by 2033, growing at a compound annual growth rate (CAGR) of around 12.2% over the forecast period of 2023-2033.The report covers all information about the global and regional markets, including historical and future trends for market dominance, size, trades, supply, competitors, and prices, as well as key vendor information across the globe. Forecast market information, SWOT analysis, NGS-based RNA-sequencing market scenario, and feasibility study are important aspects in this report.

Get a sample copy of this report: https://wemarketresearch.com/reports/request-free-sample-pdf/ngs-based-rna-sequencing-market/1061

Companies Covered: NGS-based RNA-sequencing Market:

· Illumina

· Thermo Fisher Scientific

· Pacific Biosciences

· Oxford Nanopore Technologies

· BGI Group

· Qiagen

· F. Hoffmann-La Roche AG

· Agilent Technologies

· Eurofins Scientific

· Takara Bio Inc.

The benefits of RNA sequencing over conventional technologies, the falling cost of genome sequencing, the rise in government funding for genomics projects, the expansion of RNA sequencing research, the rise in cancer cases, the growing use of NGS in cancer research, and the quick development of personalized medicine are the main factors driving this market's growth.

Global NGS-based RNA-sequencing Market Segmentation:

By Application:
• Gene expression analysis
• Differential gene expression
• Alternative splicing analysis
• SNP detection
• Fusion gene detection
• Others

By Technology:
• Targeted Sequencing
• Whole Transcriptome Sequencing

By End-User:
• Academic and research institutes
• Biotech and pharma companies
• Contract Research Organizations (CROs)
• Others (government bodies, non-profit organizations, etc.)

Global NGS-based RNA-sequencing Market Dynamics:

The size of an organism's genome determines how much sequencing will cost. Targeted sequencing, for example, is less costly than whole-genome sequencing. Data quality is a significant element that influences variances in sequencing costs, in addition to genome size. The average number of times each base in the genome is actually "read" during the sequencing process affects sequencing cost as well. Several companies are taking part in RNA sequencing studies because of the lower prices. Over the past 20 years, there has been a decrease in the price of RNA sequence per raw megabase. This has made it possible for sequencing service providers to charge less for NGS-based RNA sequencing services. As a result, as these services become more affordable, their use grows.

Technological advancements in sequencing platforms:

Constant improvements in sequencing technology have made it possible to create effective, portable, and user-friendly NGS sequencers that provide precise data quickly while reducing turnaround times. In order to strengthen their positions in this rapidly expanding sector, top businesses are thus always focused on funding research projects for the creation of new products.

Opportunities:

Thanks to developments in next-generation sequencing, such as paired-end (PE) sequencing, library preparation can now generate twice as many reads at once. In this process, reading pairs are utilized to sequence both ends of DNA fragments in the library and align forward and reverse reads. The methods have also allowed for sequences with more precise read alignment and, consequently, the capacity to identify indels, which is not possible with single-read data. The most popular and up-to-date method among researchers is the paired-end strategy.

The U.S. to Hold Lion’s Share in North America’s Market:

Due to extensive financing for genomics research and state-level assistance, North America dominates the market for NGS-based RNA sequencing. The market is expanding because to the rising incidence of target diseases and the increased research on cancer and inherited uncommon disorders. Large sums of money have already been provided by the US government for genomic research initiatives like the Human Microbiome Project and the Human Genome Project.

NGS-based RNA-sequencing Market Regional Insights:

The report provides a comprehensive examination of the factors driving growth, constraints, future prospects, and competitive landscape across all regions. The market is segmented by region into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. Additionally, the report identifies the top countries in each region and provides market forecasts for each one.

Frequently Asked Questions:

1. What are the drivers shaping various markets?

2. What are the top performing segments, and countries / regions of each of the markets?

3. What is the market size and growth projections?

Directly Purchase a Copy of this NGS-based RNA-sequencing Market research report at: https://wemarketresearch.com/purchase/ngs-based-rna-sequencing-market/1061?license=single

The research includes historical data from 2018 to 2023 and forecasts until 2033, making the report valuable to industry executives, marketing, sales and product managers, consultants, analysts, and stakeholders in clearly presented tables Together, we are looking for documents that are easily accessible graph.

Finally, the NGS-based RNA-sequencing Market report is the believable source for gaining the Market research that will exponentially accelerate your business. The report provides locales, economic conditions, item values, benefits, limits, creations, supplies, requests, market development rates, numbers, etc. NGS-based RNA-sequencing industry report additionally presents a new task SWOT exam, speculation attainability investigation, and venture return investigation.

Asia Pacific Pain Management Therapeutics Market

About We Market Research:

WE MARKET RESEARCH is an established market analytics and research firm with a domain experience sprawling across different industries. We have been working on multi-county market studies right from our inception. Over the time, from our existence, we have gained laurels for our deep rooted market studies and insightful analysis of different markets.

Contact Us:

Mr. Robbin Joseph

Corporate Sales, USA

We Market Research

USA: +1-724-618-3925

Websites: https://wemarketresearch.com/

Email: sales@wemarketresearch.com